The Drug Analysis and Research Unit received and analyzed 261 drug samples over a five-year period 1996 to 200. Samples were received from regulatory authorities, local industry, non-governmental organizations, hospitals and private practitioners. The samples analyzed constituted 59.8 % locally
manufactured and 40.2 % imported products. The overall rate of failure to comply with
quality specifications set out in the respective monographs was 21.1 %. This represents 24.6%
and 16.2 % of the locally manufactured imported drugs respectively.